BACKGROUND Type 2 diabetes (T2D) and obesity are associated with nonalcoholic fatty liver disease, cardiomyopathy,
T ype 2 diabetes (T2D) and obesity are both associated with nonalcoholic fatty liver disease (NAFLD), cardiomyopathy (1, 2) , and increased cardiovascular mortality (3, 4) . The incidence of T2D continues to increase, driven predominantly by the obesity epidemic. Although obesity is likely to be a strong contributor to diabetic cardiomyopathy (5), many patients with diabetic cardiomyopathy have normal body mass index (BMI), suggesting that diabetes and obesity may have different mechanisms by which they mediate cardiovascular change and that diabetic cardiomyopathy may occur in patients with T2D without obesity. Furthermore, evidence suggests that distribution of excess fat is an important determinant of cardiovascular risk, and ectopic and visceral adiposity confer a much higher risk than subcutaneous adiposity (6, 7) .
Ectopic and visceral fat storage may be linked to insulin resistance, and it is widely known that insulin resistance is the strongest predictor of development of diabetes (8) .
Increasing evidence points to a strong association between insulin resistance and nonischemic heart failure (9), although there are differing opinions regarding whether this relationship is of a protective or pathological nature (10) (11) (12) .
Thus, the presence of ectopic and visceral fat deposition in patients with T2D even in the absence of a global increase in total body fat may potentially play a significant role in this association. Assessing body composition is, therefore, likely to be more important in patients with T2D than simple metrics of obesity.
Liver fat is considered a key feature of ectopic fat associated with dysfunctional adipose tissue and visceral fat deposition (13) , and there is also growing interest in the imaging of epicardial adipose tissue as a proxy measure of visceral fat.
Epicardial adipose tissue, a form of visceral fat, may affect the underlying myocardium by secreting a wide range of adipokines (14) . Furthermore, excess liver fat has been shown to be accompanied by cardiac structural and functional changes (15) . Myocardial energetic compromise is an important feature of both the diabetic (17) and the nondiabetic obese heart (5 Levelt et al. Kingdom) was injected at a rate of 6 ml/s followed by a 50-ml saline flush. The scan covered a region from 1 to 2 cm above the left main coronary artery to 1 to 2 cm below the myocardial apex in a single breath hold.
E p i c a r d i a l f a t v o l u m e q u a n t i fi c a t i o n . CT images were reconstructed using medium-soft kernel (standard) with slice thickness of 0.625 mm and then transferred to a dedicated workstation for image processing (TeraRecon Aquarius iNtuition version Suitability of patients with type 2 diabetes (T2D) was assessed during the first hospital visit. Those patients who consented to have a cardiac computed tomography (CT) scan were then invited for the second hospital visit. The third hospital visit included magnetic resonance imaging (MRI) and magnetic resonance spectroscopy scans (3T).
Multiparametric liver MRI included proton magnetic resonance spectroscopy ( 1 H-MRS) for hepatic triglyceride; T 1 and T 2 * mapping yielded iron-corrected T 1 (cT 1 ). This was followed by cardiac magnetic resonance, which included cine imaging to assess left ventricular (LV) volumes, mass, and ejection fraction; myocardial tagging for assessment of peak circumferential systolic strain and diastolic strain rate; cardiac 1 H-MRS for myocardial triglyceride; and late gadolinium enhancement (LGE) imaging for exclusion of myocardial scarring. Control subjects underwent identical MRI protocols. 31 P-MRS ¼ phosphorus magnetic resonance spectroscopy; ECG ¼ electrocardiogram; HLA ¼ horizontal long axis; PCr/ATP ¼ myocardial phosphocreatine to adenosine triphosphate concentration ratio; SA ¼ short axis.
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was performed to obtain the rest PCr/ATP from a voxel placed in the midventricular septum, with the subjects lying prone with their heart over the center of the 31 P heart/liver coil in the isocenter of the magnet. LIVER MRI. The liver multiparametric MR protocol has been previously described (16) . MR scans were performed using a 3-T scanner (Tim Trio, Siemens). Levelt et al.
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DISCUSSION
This study demonstrates for the first time that diabetes, even in the absence of obesity, is associated with significant cardiac structural and metabolic abnormalities, whereas significant functional changes, such as reductions in peak systolic strain and diastolic strain rates, are only evident in obese patients with diabetes. Furthermore, we show that those patients with diabetes who are also obese have higher (23, 24) ; moreover, we also demonstrate that there is an association between fibroinflammatory liver disease and insulin resistance in patients with diabetes.
The correlation of systolic strain and diastolic strain rates with hepatic and epicardial fat and insulin resistance suggests a link between these in patients with diabetes. However, the causality of these relationships will need to be investigated in future studies.
Finally, as is widely known, the spectrum of NAFLD ranges from fatty liver alone to nonalcoholic steatohepatitis (25) . We show here that diabetes, even in the absence of obesity, is associated with hepatic steatosis at the mild end of the liver disease spec- (30, 31) , and obese subjects with T2D are at high risk of developing ectopic adiposity (32) . There are many molecular mechanisms that may contribute to the association between insulin resistance and nonischemic cardiomyopathy (9) . These include metabolic inefficiency (33) , impaired vascular function and were the first to show that hepatic triglyceride was not predictive of myocardial triglyceride (38 CCTA was not performed in normal volunteers to avoid unnecessary radiation exposure. Significant coronary artery disease was deemed to be unlikely in this normal cohort, and epicardial fat volumes were therefore only assessed and compared in Ob-and Ln-T2D patients.
For assessment of liver disease, we have not used liver biopsy, the current gold standard, because it is invasive and limited by sampling and observerdependent variability (50) . Instead, we used a recently established, noninvasive, multiparametric scanning method, which has demonstrated a high diagnostic accuracy for the assessment of liver fibrosis, steatosis, and hemosiderosis (16) .
Although the differences in mean peak systolic strain and diastolic strain rates in Ln-T2D compared with control subjects did not reach statistical significance, this may be due to the relatively small sample size. Larger studies of Ln-T2D patients are needed to confirm this. Although the release of adipokines including adiponectin and leptin has been considered among the important actions of adipocytes, we did not assess circulating levels of adiponectin or leptin.
There is evidence of a role for the sympathetic nervous system in the relationship between insulin and hypertension in obese patients with hypertension (51). We did not demonstrate any significant difference in resting heart rates or the systolic blood pressure between the 2 diabetes groups to suggest an enhanced adrenergic drive in the obese group, but we did not assess circulating catecholamine levels.
Finally, the observational nature of our findings 
